SHE:301281 - Shandong Keyuan Pharmaceutical Co Ltd

Shandong Keyuan Pharmaceutical
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized Adjust Display Metrics

Show %	2018 Q4	2019 Q4	2020 Q4	2021 Q2	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Insider Holdings (%)	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	0% -	0% -	-	-
Net Margin	[friend]	[friend]	[friend]	-	18.57% -	24.2% 30.3%	20.66% -14.6%	16.14% -21.9%	20.61% 27.7%	21.14% 2.6%	20.63% -2.4%	19.81% -4.0%	17.21% -13.1%	14.16% -17.8%
Gross Margin	[friend]	[friend]	[friend]	-	42.1% -	41.04% -2.5%	12.91% -68.5%	37.45% 190.1%	40.94% 9.3%	44.51% 8.7%	47% 5.6%	48.68% 3.6%	47.25% -2.9%	43.65% -7.6%
Operating Margin	[friend]	[friend]	[friend]	-	21.42% -	28.18% 31.6%	-14.25% -	16.44% -	22.27% 35.4%	22.47% 0.9%	19.91% -11.4%	18.46% -7.3%	14.67% -20.5%	11.51% -21.6%
Total Revenue	[friend]	[friend]	[friend]	212.6M -42.1%	420.89M 98.0%	113.43M -73.1%	432.46M 281.3%	110.28M -74.5%	442.87M 301.6%	453.66M 2.4%	443.17M -2.3%	449.1M 1.3%	447.58M -0.3%	469.63M 4.9%
Total Assets	[friend]	[friend]	[friend]	504.57M -	559.51M 10.9%	-	629.34M -	-	651.79M -	1.45B 121.9%	1.43B -1.3%	1.45B 1.7%	1.47B 1.2%	1.5B 2.3%
Total Liabilities	[friend]	[friend]	[friend]	113.03M -	128.52M 13.7%	-	147.76M -	-	132.06M -	129.21M -2.2%	121.83M -5.7%	130.8M 7.4%	138.93M 6.2%	152.04M 9.4%
Total Equity	[friend]	[friend]	[friend]	391.54M -	430.98M 10.1%	-	481.58M -	-	519.73M -	1.32B 153.4%	1.31B -0.9%	1.32B 1.2%	1.33B 0.8%	1.35B 1.5%
Operating CashFlow	[friend]	[friend]	[friend]	31.55M -70.0%	52.02M 64.9%	-	41.01M -	-	115.86M -	-	96M -	-	37.03M -	-
Beginning Cash Position	[friend]	[friend]	[friend]	37.21M 25.4%	37.21M 0%	65.35M 75.6%	70.33M 7.6%	85.2M 21.1%	65.35M -23.3%	70.33M 7.6%	85.2M 21.1%	110.74M 30.0%	148.97M 34.5%	932.4M 525.9%
End Cash Position	[friend]	[friend]	[friend]	59.8M 60.7%	65.35M 9.3%	70.33M 7.6%	85.2M 21.1%	110.74M 30.0%	148.97M 34.5%	932.19M 525.7%	294.1M -68.5%	327.62M 11.4%	324.21M -1.0%	532.39M 64.2%
Free Cash Flow	[friend]	[friend]	[friend]	31.55M -67.8%	31.83M 0.9%	5.28M -83.4%	21.05M 298.7%	25.87M 22.9%	84.75M 227.6%	80.22M -5.4%	65.03M -18.9%	21.57M -66.8%	-33.12M -	-122.15M -
Net Income (Cont Operations)	[friend]	[friend]	[friend]	39.91M -41.9%	78.17M 95.9%	-	51.07M -	-	91.28M -	-	91.42M -	-	77.04M -	-
Diluted Net Income	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-
Diluted EPS	[friend]	[friend]	[friend]	0.492 -41.7%	0.964 96.2%	0.336 -65.2%	1.101 228.1%	0.219 -80.1%	1.121 411.6%	1.179 5.1%	1.033 -12.4%	0.944 -8.6%	0.76 -19.5%	0.406 -46.6%
Return On Equity (%)	[friend]	[friend]	[friend]	-	20.24% -	-	20.46% -	-	19.2% -	7.28% -62.1%	10.23% 40.5%	6.73% -34.2%	8.33% 23.6%	4.98% -40.1%
Return On Assets (%)	[friend]	[friend]	[friend]	-	15.36% -	-	15.76% -	-	15.07% -	6.63% -56.0%	8.89% 34.0%	6.13% -31.1%	7.26% 18.5%	4.51% -37.9%